Inventurus Knowledge Solutions Ltd

Inventurus Knowl Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Inventurus Knowledge Solutions Ltd

₹ 1,619 1.81%
27 Jun - close price
ikshealth.com BSE: 544309 NSE: IKS
About

Incorporated in 2006, Inventurus Knowledge Solutions Ltd provides healthcare solutions through its care enablement platform[1]

Key Points

Business Overview:[1]
IKSL is a technology-enabled healthcare solutions provider which offer a care enablement platform assisting physician enterprises in the US, Canada and Australia, with a focus on the US markets. It partners with an outpatient and inpatient health care organizations, enabling them to deliver superior clinical care through a **fee for value model **

Website BSE NSE
  • Market Cap ₹ 27,773 Cr.
  • Current Price ₹ 1,619
  • High / Low ₹ 2,190 / 1,226
  • Stock P/E 83.7
  • Book Value ₹ 71.5
  • Dividend Yield 0.00 %
  • ROCE 35.0 %
  • ROE 32.3 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 40.5%

Cons

  • Stock is trading at 22.6 times its book value
  • Debtor days have increased from 76.8 to 116 days.
  • Working capital days have increased from 39.3 days to 97.2 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Information Technology Information Technology IT - Services IT Enabled Services

Part of BSE 500 BSE Information Technology Nifty 500 BSE MidCap BSE IPO

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2023 Mar 2024 Sep 2024 Dec 2024 Mar 2025
250 183 240 241 290
113 123 124 138 161
Operating Profit 137 60 116 103 129
OPM % 55% 33% 48% 43% 44%
7 7 6 6 2
Interest 6 7 2 4 3
Depreciation 5 7 7 7 7
Profit before tax 133 53 113 99 121
Tax % 15% 20% 18% 16% 17%
113 43 92 83 100
EPS in Rs 6.61 2.49 5.37 4.82 5.82
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
161 203 388 418 560 759 873 973
139 149 252 252 329 444 478 547
Operating Profit 22 54 136 166 231 316 394 426
OPM % 14% 27% 35% 40% 41% 42% 45% 44%
0 0 31 16 1 -3 33 15
Interest 8 8 7 7 6 5 16 11
Depreciation 5 10 36 26 19 20 22 29
Profit before tax 8 36 123 148 208 288 390 402
Tax % 0% 0% 1% 6% 9% 12% 14% 17%
8 36 122 139 189 253 337 332
EPS in Rs 10.51 44.55 148.09 168.19 11.04 14.83 19.72 19.35
Dividend Payout % 0% 0% 16% 14% 485% 0% 50% 0%
Compounded Sales Growth
10 Years: 20%
5 Years: 20%
3 Years: 20%
TTM: 12%
Compounded Profit Growth
10 Years: 45%
5 Years: 22%
3 Years: 17%
TTM: -1%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: 42%
3 Years: 41%
Last Year: 32%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 8 8 8 8 17 17 17 17
Reserves -40 -2 221 368 501 622 811 1,210
74 79 0 62 53 43 227 77
58 66 141 62 133 154 101 101
Total Liabilities 100 151 370 500 704 836 1,156 1,405
16 32 36 72 63 49 116 839
CWIP 14 26 0 0 0 0 0 5
Investments 4 4 5 16 16 19 473 6
66 88 329 412 624 767 567 554
Total Assets 100 151 370 500 704 836 1,156 1,405

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
16 52 141 168 237 248 119 274
-21 -38 -80 -165 -81 -140 -149 -104
5 -2 -36 -32 -54 -148 -186 24
Net Cash Flow 0 12 25 -30 102 -40 -216 194

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 130 101 35 23 25 32 83 116
Inventory Days
Days Payable
Cash Conversion Cycle 130 101 35 23 25 32 83 116
Working Capital Days -16 -22 -6 10 -48 -34 55 97
ROCE % 70% 47% 46% 52% 47% 35%

Shareholding Pattern

Numbers in percentages

17 Recently
Dec 2024Mar 2025
63.72% 63.72%
5.48% 5.38%
4.45% 4.02%
23.52% 24.29%
2.85% 2.58%
No. of Shareholders 67,58357,714

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

No data available.

DRHP

Concalls